Document is current

Article History

Accepted: 20 March 2025

First Online: 8 April 2025

Declarations

:

: Eli Lilly and Company provided the funding for the study and journal open-access charges.

: Wai Man Maria Chan, Debbie Tinsley, Wallace Crandall, Wendy J. Komocsar, Casey K. Choong, Payal Jha, and Theresa Hunter Gibble: Employees and shareholders of Eli Lilly. Yu Du: PhD Student, Department of Epidemiology and Biostatistics, Indiana University School of Public Health Bloomington, and Internship at Eli Lilly between January 2022 and May 2022. Art Kastl: Employment at Children's Hospital of Philadelphia.

: Study concept: WC, WK, YD, THG. Study design: WK, YD, CKC, THG. Data acquisition: AK, WMC, YD, THG. Data analysis: WMC, DT. Data interpretation: WMC, WC, WK, CKC, PJ. Drafting/revision of the article for content: all authors. All authors read and approved the final version.

: The dataset(s) supporting the conclusions of this article are included within the article as tables, figures, and supplementary material.

: The study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki and are consistent with Good Pharmacoepidemiology Practices and applicable local laws and regulations, as appropriate.

: The study used previously collected and de-identified data to protect patients’ privacy; therefore, no formal patient consent was required.

: Not applicable.

: Not applicable.